Cancer Clinical Trials: The Complete SmartCancer Guide

Q: How do I know whether I qualify for a cancer clinical trial?

Compare the trial eligibility criteria with your diagnosis, stage, biomarkers, previous treatments, medical history and other requirements. The trial team ultimately confirms eligibility.

How clinical trials work, who may qualify, how to find a trial, how to evaluate an investigational treatment, and where clinical research fits into modern precision oncology.

Clinical trials are one of the principal ways new cancer treatments, diagnostic technologies, prevention strategies and supportive-care approaches are evaluated in people.

But finding a trial is only the beginning. The more important questions are:

Is the trial relevant to this cancer? Does the patient meet the eligibility criteria? What question is the study actually testing? What are the potential benefits and risks? And how does the investigational approach compare with established treatment options?

SmartCancer Clinical Trial Principle:

CANCER TYPE
↓
STAGE + DISEASE STATUS
↓
BIOMARKERS
↓
PREVIOUS TREATMENT
↓
TRIAL ELIGIBILITY
↓
INVESTIGATIONAL INTERVENTION
↓
RESPONSE + SAFETY
↓
NEXT DECISION

A clinical trial should be understood as a structured research question—not simply as access to a “new treatment.”

What Is a Cancer Clinical Trial?

A cancer clinical trial is a research study involving people that is designed to answer specific questions about cancer prevention, screening, diagnosis, treatment, supportive care, survivorship or other aspects of cancer management.

Clinical trials may evaluate medicines, combinations of medicines, radiation approaches, surgery, cellular therapies, vaccines, diagnostic tests, monitoring technologies, behavioral interventions or supportive-care strategies.

The study protocol specifies the research question, participants, intervention, dosing or procedures, assessments, duration, safety monitoring and methods for analyzing results.

Clinical research is therefore fundamentally different from an anecdotal treatment experience. The trial is designed in advance to generate evidence that can be evaluated systematically. :contentReference[oaicite:1]{index=1}

Important distinction: Being enrolled in a clinical trial does not mean the investigational treatment is proven to work. The purpose of the trial is to determine whether an intervention is safe, effective, or otherwise useful.

Why Cancer Clinical Trials Matter

Virtually every major advance in modern cancer care has required clinical research to determine whether a new approach actually benefits patients.

Clinical trials can investigate:

New Treatments

New drugs, antibodies, cellular therapies, radiation approaches and other interventions.

New Combinations

Combining established treatments with newer therapies or testing different treatment sequences.

Precision Oncology

Matching treatments to molecular alterations or biological characteristics.

Diagnostics

New tests for detecting, classifying or monitoring cancer.

Prevention

Strategies designed to reduce the risk of developing cancer.

Supportive Care

Approaches designed to reduce symptoms, side effects or treatment burden and improve quality of life.

NCI describes clinical trials as essential to moving new approaches from laboratory and research settings toward clinical use and improved cancer care. :contentReference[oaicite:2]{index=2}

Types of Cancer Clinical Trials

Not every clinical trial is a treatment trial.

Trial Type	Main Question	Examples
Treatment	Does a treatment or combination improve outcomes?	Targeted therapy, immunotherapy, chemotherapy, ADCs, cellular therapy
Prevention	Can cancer incidence or risk be reduced?	Medicines, vaccines, lifestyle or risk-reduction strategies
Screening	Can cancer be detected earlier?	Imaging, blood tests, molecular screening
Diagnostic	Can cancer be diagnosed or characterized more accurately?	Biomarker assays, molecular tests, imaging technologies
Supportive Care	Can symptoms, side effects or quality of life be improved?	Pain, fatigue, nausea, nutrition and psychosocial interventions
Observational	What happens without researchers assigning an intervention?	Natural history, outcomes and epidemiological studies
Health Services	How can cancer care be delivered more effectively?	Access, delivery, cost and quality-of-care research

NCI's clinical-trial search distinguishes treatment, prevention, supportive-care, screening, diagnostic, basic-science and health-services research among other categories. :contentReference[oaicite:3]{index=3}

Clinical Trial Phases Explained

Drug-development trials are commonly described using phases. The purpose of each phase differs, and a higher phase does not automatically mean that a treatment is appropriate for every patient.

Phase 1 — Initial Human Testing

Phase 1 studies generally focus heavily on safety, tolerability, pharmacology and dose selection. In oncology, Phase 1 studies are commonly conducted in people with cancer rather than healthy volunteers because of the nature of investigational anticancer drugs.

Phase 2 — Preliminary Evidence of Activity

Phase 2 studies typically investigate whether an intervention shows evidence of benefit in people with a particular disease while continuing to characterize safety.

Phase 3 — Comparative Evidence

Phase 3 trials are generally larger studies designed to provide more definitive evidence about effectiveness and safety, often comparing an investigational strategy with an established treatment or control.

Phase 4 — Post-Approval Research

Phase 4 studies occur after approval and can generate additional information about safety, effectiveness, use and longer-term outcomes.

The FDA describes Phase 1 as initial human research focused on safety and pharmacologic effects, Phase 2 as early controlled research providing preliminary effectiveness data, and Phase 3 as expanded studies intended to provide additional evidence about effectiveness and safety. :contentReference[oaicite:4]{index=4}

Do not interpret trial phase as a simple quality ranking. A Phase 1 trial may be scientifically important but generally provides less evidence about clinical effectiveness than a successful Phase 3 trial.

Who Can Join a Cancer Clinical Trial?

Clinical trials have eligibility criteria specifying who may participate.

These criteria can include:

Cancer type
Cancer subtype
Disease stage
Biomarker or molecular alteration
Previous treatments
Response or progression after treatment
Age
Performance status
Organ function
Laboratory values
Medical history
Concurrent medications
Time since previous treatment
Presence or absence of brain metastases
Other clinical factors

NCI specifically notes that eligibility can depend on cancer type or stage, previous treatment, genetic changes in the tumor, age, medical history and current health status. :contentReference[oaicite:5]{index=5}

INTERESTED IN A TRIAL
↓
PRE-SCREENING
↓
ELIGIBILITY REVIEW
↓
MEDICAL ASSESSMENT
↓
INFORMED CONSENT
↓
ENROLLMENT

Finding a trial that appears relevant online does not guarantee eligibility. The trial team makes the formal determination after reviewing the relevant information.

Biomarkers and Precision Oncology Trials

One of the most important developments in modern cancer research is the increasing use of molecular and biological characteristics to identify potential trial participants.

Examples include:

EGFR ALK ROS1 KRAS BRAF RET MET HER2 NTRK MSI-H dMMR TMB PD-L1 BRCA1/2 HRD IDH1/2

A precision-oncology trial may therefore enroll patients based on a molecular feature rather than simply the anatomical location of the tumor.

Biomarker-Driven Trial Logic

CANCER
↓
MOLECULAR TESTING
↓
BIOMARKER IDENTIFIED
↓
MATCHING INVESTIGATIONAL STRATEGY
↓
ELIGIBILITY ASSESSMENT
↓
CLINICAL TRIAL

This is one reason comprehensive molecular profiling can sometimes be relevant when evaluating trial opportunities, although the appropriate testing strategy depends on the cancer and clinical context.

How to Find a Cancer Clinical Trial

There is no single database that necessarily contains every cancer trial worldwide. NCI recommends using multiple sources when appropriate, including ClinicalTrials.gov, cancer centers, pharmaceutical or biotechnology sponsors and other trial resources. :contentReference[oaicite:6]{index=6}

1. ClinicalTrials.gov

ClinicalTrials.gov is one of the major international trial registries and contains cancer studies as well as studies involving many other diseases.

Search ClinicalTrials.gov

2. National Cancer Institute

The NCI provides a cancer-specific clinical-trial search covering NCI-supported studies and trials at participating cancer centers.

Search NCI Cancer Clinical Trials

3. Major Cancer Centers

Academic cancer centers and specialist institutions often maintain their own trial listings.

4. Trial Sponsors

Pharmaceutical and biotechnology companies may publish information about sponsored studies.

5. Your Oncology Team

Your oncologist, specialist or clinical-trial office may know about trials that are particularly relevant to your diagnosis and location.

NCI recommends discussing potential trials with your healthcare team and notes that doctors can help identify appropriate studies and interpret eligibility requirements. :contentReference[oaicite:7]{index=7}

How to Search More Effectively

Searching only for a broad term such as "lung cancer" can produce a very large number of results.

A more structured search may use:

CANCER TYPE + SUBTYPE + STAGE + BIOMARKER + PRIOR TREATMENT + LOCATION + TRIAL PHASE

For example:

Non-small cell lung cancer + EGFR
Metastatic colorectal cancer + MSI-H
HER2-positive breast cancer + ADC
Metastatic prostate cancer + PSMA
BRCA-mutated ovarian cancer
KRAS G12C solid tumors

NCI's advanced search allows filtering by cancer type, age, keywords, location, trial type, drug or treatment, previous treatment, trial phase, trial ID, investigator and lead organization. :contentReference[oaicite:8]{index=8}

How to Evaluate a Cancer Clinical Trial

Finding a trial is not the same as finding an appropriate trial.

Before contacting the trial team, examine the following:

Study Objective

What specific question is the trial trying to answer?

Eligibility

Does the cancer, stage, biomarker profile and treatment history appear compatible?

Intervention

What treatment, diagnostic procedure or intervention is being studied?

Comparator

Is there a standard-treatment or placebo control?

Phase

Where is the intervention in the clinical-development process?

Location

Where is the trial conducted and how often must participants attend?

Time Commitment

How long is treatment, monitoring and follow-up expected to last?

Risks

What known and potential risks are associated with the intervention?

NCI recommends reviewing the trial objective, eligibility, location and study length before contacting the study team. :contentReference[oaicite:9]{index=9}

Questions to Ask Before Joining a Clinical Trial

About the Trial

What is the main purpose of the study?
What treatment or intervention is being tested?
Why is this trial being conducted?
What is already known about the treatment?
What phase is the trial?

About Potential Benefit

What evidence suggests the treatment may help?
Is there evidence in this particular cancer type?
Are there biomarker requirements?
What outcomes will the study measure?

About Risk

What side effects are known?
What serious risks are possible?
What happens if the cancer progresses?
Can treatment be stopped?
What monitoring is required?

About Alternatives

What standard treatments are available?
What happens if I do not join the trial?
Are there other trials that may be appropriate?
Could I receive standard treatment outside the trial?

About Practical Issues

Where is the trial located?
How frequently are visits required?
How long is participation expected to last?
What travel is required?
What costs are covered?

Benefits, Risks and Uncertainty

Clinical trials can offer potential benefits, but participation also involves uncertainty.

Potential Benefits

Access to investigational therapies
Close medical monitoring
Contribution to cancer research
Potential access to novel treatment strategies

Potential Risks

Unknown or incompletely characterized side effects
Treatment may not work
Additional procedures or testing
Travel and time burden
Potential opportunity costs

Clinical trial ≠ guaranteed breakthrough.

Many investigational treatments do not ultimately become successful cancer therapies. A trial should therefore be evaluated according to its evidence, scientific rationale, risks, alternatives and individual eligibility—not simply because the treatment is new.

Before enrollment, participants should receive information about the study and have an opportunity to ask questions before deciding whether to participate.

Informed consent is intended to help participants understand the purpose of the study, procedures, potential risks and benefits, alternatives and other important information.

Participation is voluntary. A patient should not feel pressured to participate simply because a trial is available.

Placebos and Control Groups

Some clinical trials use comparison groups to determine whether an intervention produces an effect beyond the control condition.

A control group may receive:

Standard treatment
Placebo in appropriate circumstances
Another active treatment
Observation or another predefined comparator

Whether a placebo is ethically and scientifically appropriate depends on the disease, trial design and available standard treatment.

Patients should always understand exactly what the control group receives before agreeing to participate.

Clinical Trial vs Standard Treatment

An investigational therapy and a standard-of-care treatment are not equivalent categories.

Feature	Standard Treatment	Clinical Trial
Evidence	Established evidence supporting clinical use	Evidence may range from early research to advanced comparative evidence
Regulatory Status	Generally approved or guideline-supported for the relevant use	May involve investigational use
Purpose	Patient care	Research question
Eligibility	Clinical appropriateness and treatment criteria	Specific protocol eligibility criteria
Uncertainty	Usually better characterized	May be substantially greater

Precision Oncology and Modern Trial Designs

Traditional cancer trials often focus on one cancer type.

Modern precision-oncology research can sometimes organize trials around a molecular alteration that appears across multiple cancers.

Basket Trials

A basket trial may investigate a treatment in people with different cancer types that share a particular molecular alteration or biological feature.

Umbrella Trials

An umbrella trial may focus on one cancer type while assigning different treatments based on molecular characteristics.

Platform Trials

Platform designs can evaluate multiple interventions or treatment arms within an adaptable research infrastructure.

CANCER TYPE
+
BIOMARKER
+
MOLECULAR PROFILE
+
TREATMENT HISTORY
↓
PRECISION TRIAL MATCHING

Clinical Trials for Treatment Resistance

One of the most important opportunities in precision oncology is research involving patients whose cancers have developed resistance to previous therapy.

Resistance can result from:

New mutations
Target alteration
Activation of bypass pathways
Clonal evolution
Tumor heterogeneity
Changes in the tumor microenvironment
Immune escape
Phenotypic or lineage changes

INITIAL TREATMENT
↓
RESPONSE
↓
PROGRESSION
↓
RE-BIOPSY / LIQUID BIOPSY
↓
NEW BIOMARKER
↓
RESISTANCE-DIRECTED TRIAL

This is a major connection between the SmartCancer Oncology Knowledge Graph and its Clinical Trials Knowledge Graph.

Next-Generation Cancer Clinical Trials

The oncology trial landscape is expanding beyond conventional chemotherapy and single-agent targeted drugs.

Antibody-Drug Conjugates

Antibody-based targeting linked to therapeutic payloads.

Bispecific Antibodies

Antibodies designed to engage two targets or cell populations.

CAR-T and Cellular Therapy

Engineered or selected immune-cell approaches.

TIL Therapy

Adoptive cellular therapy using tumor-infiltrating lymphocytes.

Radioligand Therapy

Molecular targeting combined with radioactive payloads.

Personalized Cancer Vaccines

Strategies designed around tumor-specific antigens or neoantigens.

AI-Enabled Oncology

AI-assisted drug discovery, diagnostics, biomarker identification and clinical development.

Multi-Omics

Integration of genomic, transcriptomic, proteomic and other biological information.

ctDNA and MRD

Research into molecular monitoring and earlier detection of residual or recurrent disease.

International Cancer Clinical Trials

Cancer research is global. Relevant trials may be conducted across different countries, institutions and healthcare systems.

When considering an international trial, additional questions become important:

Where is the trial site?
Does the study accept international participants?
What documentation is required?
Are medical records required in English?
What travel is required?
Who pays for travel and accommodation?
What happens if complications occur after returning home?
How will follow-up care be coordinated?
What local regulatory requirements apply?

International access should never be assumed merely because a trial appears in an online registry.

SmartCancer Clinical Trial Search Checklist

Before Searching

Exact cancer diagnosis
Cancer subtype
Stage
Current disease status
Biomarker results
Previous treatments
Current treatment
Important medical conditions
Current medications
Preferred geographic region

When You Find a Trial

Trial title
ClinicalTrials.gov identifier or other registry identifier
Recruitment status
Trial phase
Study objective
Eligibility criteria
Investigational intervention
Comparator
Primary outcome
Secondary outcomes
Study location
Contact information

Before Enrolling

Discuss the trial with your oncology team.
Understand potential benefits and risks.
Understand available standard treatment.
Ask about alternative trials.
Understand the time and travel commitment.
Read the informed-consent materials carefully.
Ask what happens if the cancer progresses.

NCI's own six-step framework similarly recommends gathering cancer details, finding trials, reviewing the protocol, contacting the trial team, asking questions and then making an informed decision. :contentReference[oaicite:10]{index=10}

SmartCancer Clinical Trial Knowledge Graph

The Clinical Trials pillar should ultimately become a connected node inside the larger SmartCancer Oncology Knowledge Graph.

CANCER TYPE
↓
STAGE
↓
BIOMARKER
↓
TREATMENT HISTORY
↓
DISEASE STATUS
↓
TRIAL
↓
ELIGIBILITY
↓
INVESTIGATIONAL THERAPY
↓
CLINICAL OUTCOME
↓
RESPONSE / RESISTANCE
↓
NEXT TRIAL OR STANDARD TREATMENT

Core Clinical Trial Entities

Cancer Type Stage Biomarker Intervention Comparator Trial Phase Eligibility Recruitment Status Location Sponsor Principal Investigator Outcome Adverse Events Resistance

Future SmartCancer Clinical Trial Explorer

Proposed interactive architecture:

1. Select cancer

2. Select stage

3. Enter biomarkers

4. Enter previous treatments

5. Select disease status

6. Select location

7. Select trial phase

8. Select trial type

Output: potentially relevant clinical-trial categories and links to authoritative registries for verification.

Important design principle: A SmartCancer trial-matching tool should be a navigation and education system, not an automated medical decision-maker. Trial eligibility must ultimately be confirmed by the study team.

Understanding Clinical Trial Recruitment Status

Trial listings may use different recruitment statuses. Users should always check the current registry record rather than relying on an old article, social-media post or third-party listing.

Common concepts include:

Not yet recruiting: The study has not begun enrolling participants.
Recruiting: Participants are currently being enrolled.
Active, not recruiting: The study is continuing but not currently enrolling new participants.
Enrolling by invitation: Participation is restricted to people specifically invited.
Completed: The study has finished.
Suspended: Enrollment or study activity has been temporarily stopped.
Terminated: The study was stopped before planned completion.

Because recruitment status can change, users should verify the current record directly with the registry and trial team.

SmartCancer Clinical Trial Evidence Framework

SmartCancer should distinguish the existence of a trial from the strength of evidence generated by that trial.

E0 — Hypothesis

Scientific rationale without meaningful human evidence.

E1 — Preclinical

Laboratory or animal evidence.

E2 — Phase 1 / Early Clinical

Initial human safety, dosing and preliminary activity.

E3 — Phase 2

More focused clinical evidence concerning activity and safety.

E4 — Phase 3

Comparative evidence capable of substantially informing benefit-risk assessment.

E5 — Established Clinical Use

Evidence has supported regulatory approval and/or established guideline-supported use for a defined indication.

A trial at an early phase should never be described as proof that an intervention works.

Common Cancer Clinical Trial Myths

Myth: Clinical trials are only for people who have run out of treatment options.

Reality: Clinical trials can occur across the cancer journey, including prevention, screening, diagnosis, early-stage disease, advanced disease and supportive care. NCI notes that people at different stages may participate when they meet eligibility requirements. :contentReference[oaicite:11]{index=11}

Myth: A clinical trial is a guaranteed access route to the newest treatment.

Reality: Trials test hypotheses. The investigational intervention may not work and may have risks that are not fully understood.

Myth: You always need your doctor's referral to search for a trial.

Reality: Patients can search for trials themselves, although discussing potential trials with their healthcare team is strongly advisable. :contentReference[oaicite:12]{index=12}

Myth: If a trial appears online, I am eligible.

Reality: Eligibility is determined according to the study protocol and ultimately confirmed by the trial team.

Myth: Phase 3 automatically means the treatment is proven for every cancer.

Reality: Phase describes the development stage of the study. The specific indication, population, intervention and results still matter.

SmartCancer Patient Clinical Trial Journey

DIAGNOSIS
↓
UNDERSTAND CANCER TYPE + STAGE
↓
MOLECULAR / BIOMARKER TESTING WHEN APPROPRIATE
↓
DISCUSS STANDARD OPTIONS
↓
SEARCH FOR RELEVANT TRIALS
↓
CHECK ELIGIBILITY
↓
COMPARE BENEFITS + RISKS
↓
DISCUSS WITH ONCOLOGY TEAM
↓
INFORMED CONSENT
↓
ENROLLMENT
↓
MONITORING
↓
RESPONSE / TOXICITY ASSESSMENT
↓
FOLLOW-UP

Frequently Asked Questions

What is a cancer clinical trial?

A cancer clinical trial is a structured research study involving people that evaluates a treatment, diagnostic method, prevention strategy, supportive-care intervention or other research question.

Are clinical trials only for advanced cancer?

No. Clinical research can involve prevention, screening, diagnosis, early-stage disease, advanced cancer, recurrence and supportive care. Eligibility depends on the individual study.

What is Phase 1?

Phase 1 generally focuses on initial human safety, tolerability, pharmacology and dose selection.

What is Phase 2?

Phase 2 generally provides preliminary evidence about effectiveness while continuing safety evaluation.

What is Phase 3?

Phase 3 generally involves larger studies designed to provide more definitive comparative evidence concerning effectiveness and safety.

Can biomarkers help identify clinical trials?

Yes. Many precision-oncology trials use molecular or biological characteristics as part of eligibility criteria.

Where can I find cancer clinical trials?

Major resources include ClinicalTrials.gov, the National Cancer Institute, cancer centers, research institutions and trial sponsors. NCI recommends checking multiple sources because no single list necessarily contains every trial. :contentReference[oaicite:13]{index=13}

How do I know whether I qualify?

Compare the trial's eligibility criteria with your diagnosis, stage, biomarkers, previous treatments, medical history and other requirements. The trial team must ultimately confirm eligibility.

Should I discuss a clinical trial with my oncologist?

Yes. Your oncology team can help you compare the trial with standard treatment and other available options.

Can a clinical trial be stopped?

Yes. Studies can be suspended or terminated for scientific, operational, safety or other reasons.

Conclusion: Clinical Trials Are the Bridge Between Discovery and Cancer Care

Clinical trials are where promising cancer discoveries are tested in humans.

But the existence of a trial is not proof that an intervention works.

The right way to approach clinical research is to connect:

CANCER
+
STAGE
+
BIOMARKERS
+
TREATMENT HISTORY
+
TRIAL DESIGN
+
EVIDENCE
+
RISK
+
ALTERNATIVES

That is the foundation of the SmartCancer Clinical Trials Knowledge Graph.

Instead of simply asking, "What cancer trials are available?", SmartCancer should help patients and families ask a much better question:

"Which clinical research questions are relevant to this cancer, this biology, this treatment history and this point in the patient's journey?"

This approach connects clinical trials to the broader SmartCancer Oncology Knowledge Graph—linking cancer type, biomarkers, treatment, resistance, monitoring and next-generation oncology research.

Medical and research disclaimer: This article is an educational resource and is not medical advice. SmartCancer does not determine whether an individual is eligible for a clinical trial and does not guarantee the safety or effectiveness of any investigational treatment. Clinical-trial information can change. Always verify recruitment status, eligibility criteria, trial details and contact information in the current official registry and with the study team. Discuss potential participation with qualified healthcare professionals.

SmartCancer Clinical Trials Pillar Page
Part of the SmartCancer Oncology Knowledge Graph
Clinical Research • Precision Oncology • Biomarkers • Investigational Therapies • Cancer Treatment